AzurRx BioPharma Reaches Enrollment Target for Phase II OPTION Clinical Trial

NEXT STORY
Global Vaccines Market Growth Opportunities – Forecast to 2024 by Production System, Antigens, Procurement System, and End Users
PREV STORY
Albireo Announces Data on Pediatric Cholestatic Liver Diseases to be Presented at the 2019 ESPGHAN Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases

author_avatar
NASDAQ Market News

Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study

author_avatar
NASDAQ Market News

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

author_avatar
NASDAQ Market News